InvivoGen's product citations
InvivoGen’s products are frequently cited in peer-reviewed publications for a wide variety of applications and uses. Browse our product citations below.
Please note: By clicking on the product name, you can access via the ‘Citations’ tab all references of the product (click ‘load more’).
Citations search
You can search by ‘Product Name’ or ‘Year’.
Product | Citation | Year | Journal | Authors | Page |
---|---|---|---|---|---|
Plasmocin® - Mycoplasma Elimination Reagent | The mitophagy receptor NIX induces vIRF-1 oligomerization and interaction wit... | 2023 | PLoS Pathog. | Vo M.T. et al. | DOI: 10.1371/journal.ppat.1011548 |
Anti-hIL-1β-IgG | IL1R1+ cancer-associated fibroblasts drive tumor development and immunosuppre... | 2023 | Nat Commun. | Koncina E. et al. | DOI: 10.1038/s41467-023-39953-w |
PHA-P | CDK7 controls E2F-and MYC-driven proliferative and metabolic vulnerabilities ... | 2023 | Blood | Yao Y. et al. | DOI: 10.1182/blood.2022018885 |
PHA-P | Cross‐platform immunophenotyping of human peripheral blood mononuclear cells ... | 2023 | Cytometry A | Heubeck A. et al. | DOI: 10.1002/cyto.a.24715 |
PHA-P | Discovery of novel resorcinol biphenyl ether-based macrocyclic small molecule... | 2023 | Bioorg Chem. | Yang Z. et al. | DOI: 10.1016/j.bioorg.2023.106740 |
G418 (Geneticin) | Incorporation of a Toll-like receptor 2/6 agonist potentiates mRNA vaccines a... | 2023 | Signal Transduct Target Ther. | Gu Y. et al. | DOI: 10.1038/s41392-023-01479-4 |
Pam2CSK4 | Characterization of the Antimicrobial Activities of Trichoplusia ni Cecropin ... | 2023 | Pharmaceutics | Lee H. et al. | DOI: 10.3390/pharmaceutics15061752 |
LPS-EB (LPS from E. coli O111:B4) | Characterization of the Antimicrobial Activities of Trichoplusia ni Cecropin ... | 2023 | Pharmaceutics | Lee H. et al. | DOI: 10.3390/pharmaceutics15061752 |
Imiquimod (R837) | Characterization of the Antimicrobial Activities of Trichoplusia ni Cecropin ... | 2023 | Pharmaceutics | Lee H. et al. | DOI: 10.3390/pharmaceutics15061752 |
Pam3CSK4 | Characterization of the Antimicrobial Activities of Trichoplusia ni Cecropin ... | 2023 | Pharmaceutics | Lee H. et al. | DOI: 10.3390/pharmaceutics15061752 |
ODN 1826 - TLR9 ligand | Characterization of the Antimicrobial Activities of Trichoplusia ni Cecropin ... | 2023 | Pharmaceutics | Lee H. et al. | DOI: 10.3390/pharmaceutics15061752 |
Human TLR4 Reporter HEK293 Cells (NF-κB) | Characterization of the Antimicrobial Activities of Trichoplusia ni Cecropin ... | 2023 | Pharmaceutics | Lee H. et al. | DOI: 10.3390/pharmaceutics15061752 |
HEK-Blue™ Detection | Characterization of the Antimicrobial Activities of Trichoplusia ni Cecropin ... | 2023 | Pharmaceutics | Lee H. et al. | DOI: 10.3390/pharmaceutics15061752 |
QUANTI-Luc™: Luciferase Detection Reagent | Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3... | 2023 | PLoS One | Trova S. et al. | DOI: 10.1371/journal.pone.0288162 |
ASC-GFP Reporter Monocytes | Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3... | 2023 | PLoS One | Trova S. et al. | DOI: 10.1371/journal.pone.0288162 |
LPS-EK (LPS from E. coli K12) | Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3... | 2023 | PLoS One | Trova S. et al. | DOI: 10.1371/journal.pone.0288162 |
THP1-defCASP1 Cells | Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3... | 2023 | PLoS One | Trova S. et al. | DOI: 10.1371/journal.pone.0288162 |
TLR4 KO Dual Reporter THP-1 Cells | Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3... | 2023 | PLoS One | Trova S. et al. | DOI: 10.1371/journal.pone.0288162 |
THP1-Dual™ Cells | Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3... | 2023 | PLoS One | Trova S. et al. | DOI: 10.1371/journal.pone.0288162 |
NLRP3 KO & KD THP-1 Cells | Pathogen and human NDPK-proteins promote AML cell survival via monocyte NLRP3... | 2023 | PLoS One | Trova S. et al. | DOI: 10.1371/journal.pone.0288162 |